Next Quarterly Earnings
Thursday, May 20, 2027
Expected
Hemab Therapeutics Holdings
Hemab Therapeutics Holdings is a US-based biotechnology company specializing in the development of innovative therapies for rare blood clotting disorders. Through cutting-edge research, Hemab focuses on treating previously underserved hematological diseases and advancing essential clinical solutions.
Frequently asked questions
When did Hemab Therapeutics Holdings last report quarterly earnings?
Hemab Therapeutics Holdings last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.80 USD.
How do I add the Hemab Therapeutics Holdings earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Company Information
Name
Hemab Therapeutics Holdings
Country
🇺🇸
More Financial Information